Analysis of C-reactive protein levels and febrile tendency after joint surgery in rheumatoid arthritis patients treated with a perioperative 4-week interruption of tocilizumab
Ryo Hiroshima1 , Kosei Kawakami1 , Takuji Iwamoto1 , Asami Tokita1 , Koichiro Yano1 , Yu Sakuma1 , Katsunori Ikari1 , Shigeki Momohara1
30 March 2010
26 July 2010
8 September 2010
PDF (member's only)
Without Abstract
Anti IL-6 receptor blocker - C-reactive protein - Orthopedic joint surgery - Rheumatoid arthritis - Tocilizumab